WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes

Genes and Development

Volumn 12, Issue 20, 1998, Pages 3217-3225

  Davies, Rachel C ^a   Calvio, Cinzia ^b   Bratt, Eva ^a,c   Larsson, Stefan H ^a,c,e   Lamond, Angus I ^d   Hastie, Nicholas D ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

^e BOSTON CONSULTING GROUP   (United States)

Author keywords

Alternative splicing; Spliceosome; U2AF65; WT1

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA PRECURSOR; TRANSCRIPTION FACTOR;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; DENYS DRASH SYNDROME; DNA BINDING; IMMUNOPRECIPITATION; MULTIPLE MALFORMATION SYNDROME; NEPHROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; RNA SPLICING; SPLICEOSOME;

ANIMALIA;

EID: 0032532734     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.20.3217     Document Type: Article

References (41)

1. Abovich, N. and M. Rosbash. 1997. Cross-intron bridging interactions in the yeast commitment complex are conserved in mammals. Cell 89: 403-412.
2. Barbaux, S., P. Niaudet, M.-C. Gubler, J.-P. Grünfield, F. Jaubert, F. Kuttenn, C.N. Fékété, N. Souleyreau-Therville, E. Thibaud, M. Fellous, and K. McElreavey. 1997. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat. Genet. 17: 467-470.
3. Berglund, J.A., N. Abovich, and M. Rosbash. 1998. A cooperative interaction between U2AF65 and mBBP/SF1 facilitates branchpoint recognition. Genes & Dev. 12: 858-867.
4. Bennett, M., S. Michaud, J. Kingston, and R. Reed. 1992. Protein components specifically associated with prespliceosome and spliceosome complexes. Genes & Dev. 6: 1986-2000.
5. Bickmore, W.A., K. Oghene, M.H. Little, A. Seawright, V. van Heyningen, and N.D. Hastie. 1992. Modulation of DNA binding specificity by alternative splicing of the Wilms' tumour wt1 gene transcript. Science 257: 235-237.
6. Bohmann, K., J.A. Ferreira, and A.I. Lamond. 1995. Mutational analysis of p80 coilin indicates a functional interaction between coiled bodies and the nucleolus. J. Cell Biol. 131: 817-831.
7. Breuning, W. and J. Pelletier, 1996. A non-AUG transitional initiation event generates novel WT1 isoforms. J. Biol. Chem. 271: 8646-8654.
8. Caricasole, A., A. Duarte, S.H. Larsson, N.D. Hastie, M. Little, G. Holmes, I. Todorov, and A. Ward. 1996. RNA binding by the Wilms' tumour suppressor zinc finger proteins. Proc. Natl. Acad. Sci. 93: 7562-7566.
9. Dignam, J.D., R.M. Lebovitz, and R.G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11: 1475-1489.
10. Estojak, J., R. Brent, and E.A. Golemis. 1995. Correlation of two-hybrid affinity data with in vitro measurements. Mol. Cell. Biol. 15: 5820-5829.
11. 65 recruits a novel human DEAD box protein required for the U2 snRNP-branchpoint interaction. Genes & Dev. 11: 1864-1872.
12. 65 to sites of active splicing in the nucleus. J. Cell Biol. 137: 975-987.
13. Haber, D.A., R.L. Sohn, A.J. Buckler, J. Pelletier, K.M. Call, and D.E. Housman. 1991. Alternative splicing and genomic structure of the Wilms tumour gene WT1. Proc. Natl. Acad. Sci. 88: 9618-9622.
14. Habcts, W.J., M.H. Hoet, B.A.W. de Jong, A. van der Kemp, and W.J. van Venrooij. 1989. Mapping of B cell epitopes on small nuclear riboproteins that react with human autoantibodies as well as with experimentally-induced mouse monoclonal antibodies. J. Immunol. 143: 2560-2566.
15. Harlow, E. and D. Lane. 1988. Antibodies: A laboratory manual. Cold Spring Habor Laboratory, Cold Spring Harbor, NY.
16. Harper, J.W., G.R. Adami, N. Wei, K. Keyomarsi, and S.J. Elledge. 1993. The p21 cdk-interacting protein is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
17. Harshman, K.D., W.S. Moye-Rowley, and C.S. Parker. 1988. Transcriptional activation by the SV40 AP-1 recognition element in yeast is mediated by a factor similar to AP-1 that is distinct from GCN4. Cell 53: 321-330.
18. Hastie, N.D. 1994. The genetics of Wilms' tumour - A case of disrupted development. Annu. Rev. Biochem. 28: 523-558.
19. Kennedy, D., T. Ramsdale, J. Mattick, and M. Little. 1996. An RNA recognition motif in Wilms' tumour protein (WT1) revealed by structural modelling. Nat. Genet. 12: 329-332.
20. Kent, J., A.-M. Coriat, P.T. Sharpe, N.D. Hastie, and V. van Heyningen. 1995. The evolution of WT1 sequence and expression pattern in the vertebrates. Oncogene 11: 1781-1792.
21. Kim, E., L. Du, D.B. Bregman, and S.L. Warren. 1997. Splicing factors associate with hyperphosphorylated RNA polymerase II in the absence of pre-mRNA. J. Cell Biol. 136: 19-28.
22. Konarska, M.M. and P.A. Sharp. 1987. Interactions between small nuclear ribonuclear particles in formation of spliceosomes. Cell 49: 763-774.
23. Kreidberg, J.A.,H. Sariola, J. M. Loring, M. Maeda, J. Pelletier, D. Housman, and R. Jaenisch. 1993. WT-1 is required for early kidney development. Cell 74: 679-691.
24. Larsson, S.H., J.P. Charlieu, K. Miyagawa, D. Engelkamp, M. Rassoulzadegan, A. Ross, F. Cuzin, V. van Heyningen, and N.D. Hastie. 1995. Subnuclear localisation of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell 81: 391-401.
25. Lerner, E.A., M.R. Lerner, C.A. Janeway, and J.A. Steitz. 1981. Monoclonal antibody to nucleic acid-containing cellular constituents: Probes for molecular biology and autoimmune disease. Proc. Natl. Acad. Sci. 78: 2737-2741.
26. Lin, Y.S. and M.R. Green. 1991. Mechanism of action of an acidic transcriptional activator in vitro. Cell 64: 971-981.
27. Little M. and C. Wells. 1997. A clinical overview of WT1 gene mutations. Hum. Mut. 9: 209-225.
28. Misteli, T., J. Cáceres, and D.L. Spector. 1997. The dynamics of a pre-mRNA splicing factor in living cells. Nature 387: 523-527.
29. Nachtigal, M.W., Y. Hirokawa, D.L. Enyeart-VanHouten, J.N. Flanagan, G.D. Hammer and H.A. Ingraham. 1998. Wilms' tumour 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell 93: 445-454.
30. Neugebauer, K.M. and M.B. Roth. 1997. Transcription units as RNA processing units. Genes & Dev. 11: 3279-3285.
31. Pritchard-Jones, K., S. Fleming, D. Davidson, W. Bickmore, D. Porteous, C. Gosden, J. Bard, A. Buckler, J. Pelletier, D. Housman, V. van Heyningen, and N. Hastie. 1990. The candidate Wilms' tumour gene is involved in genitourinary development. Nature 346: 194-197.
32. Rauscher, F.J., J.F. Morris, O.E. Tounay, D.M. Cook, and T. Curran. 1990. Binding of the Wilms' tumour locus zinc finger protein to the EGR-1 consensus sequence. Science 250: 1259-1262.
33. Reddy, J.C., J.C. Morris, J. Wang, M.A. English, D.A. Haber, Y. Shi, and J.D. Licht. 1995. WT1-mediated transcriptional activation is inhibited by dominant negative mutant proteins. J. Biol. Chem. 270: 10878-10884.
34. Reed, R., J. Griffith, and T. Maniatis. 1988. Purification and visualisation of native spliceosomes. Cell 53: 949-961.
35. Sharma, P.M., M. Bowman, S.L. Madden, F.J. Rauscher, and S. Sukumar. 1994. RNA editing in the Wilms' tumor susceptibility gene, WT1. Genes & Dev. 8: 720-731.
36. 65 and SR proteins in splicing of pre-mRNA. Nature 388: 397-400.
37. Turner, B.M. and L. Franchi. 1987. Identification of protein antigens associated with the nuclear matrix and with clusters of interchromatin granules in both interphase and mitotic cells. J. Cell Sci. 87: 269-282.
38. Valcárcel, J., R.K. Gaur, R. Singh, and M.R. Green. 1996. Interaction of U2AF65 RS region with pre-mRNA branchpoint and promotion of base pairing with U2 snRNA. Science 273: 1706-1709.
39. Wang, Z.Y., Q.Q. Qiu, and T.F. Dueul. 1993. The Wilms' tumour gene product WT1 activates or represses transcription through separate functional domains. J. Biol. Chem. 268: 9172-9175.
40. Wu, J.Y. and T. Maniatis. 1993. Specific interactions between proteins implicated in splice site selection and regulated alternative splicing. Cell 75: 1061-1070.
41. Zamore, P.D., J.G. Patton, and M.R. Green. 1992. Cloning and domain structure of the mammalian splicing factor U2AF. Nature 355: 609-614.